1. mTOR Signaling in Parkinson’s Disease

   • Ai-ping Lan
   • Jun Chen
   • Yi Hu

   Review Paper 04 June 2016 Pages: 1 - 10

   

2. Epigenetic Modifications and Therapy in Multiple Sclerosis

   • Saeed Aslani
   • Naser Jafari
   • Mahmoud Jafarnejad

   Review Paper 06 July 2016 Pages: 11 - 23

   

3. GC and VDR SNPs and Vitamin D Levels in Parkinson’s Disease: The Relevance to Clinical Features

   • Duygu Gezen-Ak
   • Merve Alaylıoğlu
   • Erdinç Dursun

   Original Paper 09 June 2016 Pages: 24 - 40

4. Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients

   • Mafalda Raposo
   • Conceição Bettencourt
   • Manuela Lima

   Original Paper 31 May 2016 Pages: 41 - 45

   

5. Increased Plasma Levels of Select Deoxy-ceramide and Ceramide Species are Associated with Increased Odds of Diabetic Neuropathy in Type 1 Diabetes: A Pilot Study

   • Samar M. Hammad
   • Nathaniel L. Baker
   • DCCT/EDIC Group of Investigators

   Original Paper 07 July 2016 Pages: 46 - 56

   

6. Antidepressant-Like and Anxiolytic-Like Effects of ZBD-2, a Novel Ligand for the Translocator Protein (18 kDa)

   • Dong-sheng Wang
   • Jing Han
   • Ming-gao Zhao

   Original Paper 20 August 2016 Pages: 57 - 68

   

7. Integrins AV and B8 Gene Polymorphisms and Risk for Intracerebral Hemorrhage in Greek and Polish Populations

   • Efthimios Dardiotis
   • Vasileios Siokas
   • Georgios M. Hadjigeorgiou

   Original Paper 30 July 2016 Pages: 69 - 80

8. Identification of Novel SCIRR69-Interacting Proteins During ER Stress Using SILAC-Immunoprecipitation Quantitative Proteomics Approach

   • Yujian Chen
   • Yong Liu
   • Shaojun Liu

   Original Paper 03 August 2016 Pages: 81 - 93

   

9. Association of GWAS-Supported Variants rs556621 on Chromosome 6p21.1 with Large Artery Atherosclerotic Stroke in a Southern Chinese Han Population

   • Hao Zhang
   • Qijin Zhai
   • Gelin Xu

   Original Paper 27 August 2016 Pages: 94 - 100

10. Parthenolide, an NF-κB Inhibitor Ameliorates Diabetes-Induced Behavioural Deficit, Neurotransmitter Imbalance and Neuroinflammation in Type 2 Diabetes Rat Model

    • Pragyanshu Khare
    • Ashok K. Datusalia
    • Shyam S. Sharma

    Original Paper 23 August 2016 Pages: 101 - 112

    

11. Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways

    • Patrícia S. Guerreiro
    • Joana E. Coelho
    • Teresa F. Pais

    Original Paper 17 August 2016 Pages: 113 - 121

    

12. Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury

    • Tanja Emmerich
    • Laila Abdullah
    • Fiona Crawford

    Original Paper 19 August 2016 Pages: 122 - 135

    

13. The Effects of Alpha Boswellic Acid on Reelin Expression and Tau Phosphorylation in Human Astrocytes

    • Esmat Fathi
    • Fatemeh Hedayati Katouli
    • Reza Nazari

    Original Paper 27 August 2016 Pages: 136 - 146

    

14. Pro198Leu Polymorphism in the Glutathione Peroxidase 1 Gene Contributes to Diabetic Peripheral Neuropathy in Type 2 Diabetes Patients

    • Monika Buraczynska
    • Kinga Buraczynska
    • Andrzej Ksiazek

    Original Paper Open access 03 September 2016 Pages: 147 - 153

15. Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer’s Disease and Other Neurodegenerative Disorders

    • Pashtun Shahim
    • Kaj Blennow
    • Henrik Zetterberg

    Original Paper 19 September 2016 Pages: 154 - 160

    

16. Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia

    • Diana Carranza
    • Ana Karina Vega
    • Ignacio J. Molina

    Original Paper 23 September 2016 Pages: 161 - 174

    

17. Erratum to: GC and VDR SNPs and Vitamin D Levels in Parkinson’s Disease: The Relevance to Clinical Features

    • Duygu Gezen-Ak
    • Merve Alaylıoğlu
    • Erdinç Dursun

    Erratum 21 July 2016 Pages: 175 - 180